Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N van Geel

Showing results (111-120 of 233) with videos related to

Pageof 24
Sort By:
Surgery|January 1, 1994
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalanJ M Klaase, B B Kroon, A N van Geel, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 24, 2009
Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremitiesDirk J G Grünhagen, Johannes H W de Wilt, Albertus N van Geel, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 1, 1995
Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactionsB C Vrouenraets, J M Klaase, B B Kroon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 30, 2000
Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: the adverse effect of radiotherapyC M Contant, A N van Geel, B van der Holt, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1999
[Second Opinion Consult Clinic for Surgical Oncology in the Daniel den Hoed Clinic: analysis of the first 245 patients]W A Mellink, S C Henzen-Logmans, A H Bongaerts, et al.
Journal of Surgical Oncology|April 1, 1993
Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremitiesB C Vrouenraets, B B Kroon, J M Klaase, et al.
World Journal of Surgical Oncology|November 23, 2006
Giant solitary fibrous tumour of the liverTürkan Terkivatan, Mike Kliffen, Johannes H W de Wilt, et al.
Cancer|May 15, 1993
A retrospective comparative study evaluating the results of a single-perfusion versus double-perfusion schedule with melphalan in patients with recurrent melanoma of the lower limbJ M Klaase, B B Kroon, A N van Geel, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 12, 2005
[Practice guideline 'Diagnostic techniques for soft tissue tumours and treatment of soft tissue sarcomas (revision)']A N van Geel, H K Wyrdeman, C Seynaeve, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 25, 2005
[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]A C J van Akkooi, J H W de Wilt, A N van Geel, et al.
Pageof 24

Showing results (111-120 of 233) with videos related to

Sort By:
Pageof 24
Surgery|January 1, 1994
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalanJ M Klaase, B B Kroon, A N van Geel, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 24, 2009
Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremitiesDirk J G Grünhagen, Johannes H W de Wilt, Albertus N van Geel, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 1, 1995
Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactionsB C Vrouenraets, J M Klaase, B B Kroon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 30, 2000
Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: the adverse effect of radiotherapyC M Contant, A N van Geel, B van der Holt, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1999
[Second Opinion Consult Clinic for Surgical Oncology in the Daniel den Hoed Clinic: analysis of the first 245 patients]W A Mellink, S C Henzen-Logmans, A H Bongaerts, et al.
Journal of Surgical Oncology|April 1, 1993
Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremitiesB C Vrouenraets, B B Kroon, J M Klaase, et al.
World Journal of Surgical Oncology|November 23, 2006
Giant solitary fibrous tumour of the liverTürkan Terkivatan, Mike Kliffen, Johannes H W de Wilt, et al.
Cancer|May 15, 1993
A retrospective comparative study evaluating the results of a single-perfusion versus double-perfusion schedule with melphalan in patients with recurrent melanoma of the lower limbJ M Klaase, B B Kroon, A N van Geel, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 12, 2005
[Practice guideline 'Diagnostic techniques for soft tissue tumours and treatment of soft tissue sarcomas (revision)']A N van Geel, H K Wyrdeman, C Seynaeve, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 25, 2005
[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]A C J van Akkooi, J H W de Wilt, A N van Geel, et al.
Pageof 24